SCHEMBL19626766

SCHEMBL19626766

CN(C)S(=O)(=O)c1cccc(-c2csc(C(C)(C)C)n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GFER P55789 3/20 0.56
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ ALDH1A1 P00352 8/20 0.52
▸ HPGD P15428 4/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ TP53 P04637 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ GAA P10253 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ KDM4E B2RXH2 5/20 0.49
▸ GLA P06280 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.46
▸ PTGES2 Q9H7Z7 1/20 0.44
▸ USP2 O75604 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626762 0.85 GFER (0.74) GFERL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL19625388 0.84 KDM4E (0.55) GFERALDH1A1HPGDHSD17B10MEN1
SCHEMBL19625383 0.77 SMN1; SMN2 (0.46) GFERALDH1A1HPGDHSD17B10MEN1
SCHEMBL12868318 0.76 ATP4A (0.55) ALDH1A1HPGDMEN1KMT2ANPC1
SCHEMBL15306545 0.75 ALDH1A1 (0.50) GFERL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL19625408 0.74 HTT (0.74) ALDH1A1HPGDHSD17B10MEN1KMT2A
SCHEMBL19625399 0.74 ATP4A (0.59) GFERL3MBTL1MEN1KMT2ATSHR
SCHEMBL12293307 0.74 CYP19A1 (0.55) NPC1RAB9ATSHRGAAMAPT
SCHEMBL19625319 0.74 MAPT (0.62) L3MBTL1ALDH1A1HPGDMEN1KMT2A
SCHEMBL19625325 0.74 KDM4E (0.62) L3MBTL1ALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 — — US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 GFER 3033/4885L3MBTL1 2626/4885ALDH1A1 1166/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 GFER 3033/4885L3MBTL1 2626/4885ALDH1A1 1166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback